| A new rating scale for age-related white matter changes applicable to MRI and CT LO Wahlund, F Barkhof, F Fazekas, L Bronge, M Augustin, M Sjogren, ... Stroke 32 (6), 1318-1322, 2001 | 2065 | 2001 |
| Measurement of phosphorylated tau epitopes in the differential diagnosisof Alzheimer disease: a comparative cerebrospinal fluid study H Hampel, K Buerger, R Zinkowski, SJ Teipel, A Goernitz, N Andreasen, ... Archives of general psychiatry 61 (1), 95-102, 2004 | 587 | 2004 |
| Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization E Vanmechelen, H Vanderstichele, P Davidsson, E Van Kerschaver, ... Neuroscience letters 285 (1), 49-52, 2000 | 560 | 2000 |
| Psychiatry of old age NL Graham, T Emery, JR Hodges, TB Gislason, M Sjögren, L Larsson, ... Journal of Neurology, Neurosurgery & Psychiatry 75 (1), 61-71, 2004 | 555* | 2004 |
| High total cholesterol levels in late life associated with a reduced risk of dementia MM Mielke, PP Zandi, M Sjogren, D Gustafson, S Ostling, B Steen, ... Neurology 64 (10), 1689-1695, 2005 | 544 | 2005 |
| Tau and Aβ42 in cerebrospinal fluid from healthy adults 21–93 years of age: establishment of reference values M Sjogren, H Vanderstichele, H Ågren, O Zachrisson, M Edsbagge, ... Clinical chemistry 47 (10), 1776-1781, 2001 | 522 | 2001 |
| Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia E Tarkowski, R Issa, M Sjögren, A Wallin, K Blennow, A Tarkowski, ... Neurobiology of aging 23 (2), 237-243, 2002 | 420 | 2002 |
| The future of blood-based biomarkers for Alzheimer's disease K Henriksen, SE O’Bryant, H Hampel, JQ Trojanowski, TJ Montine, ... Alzheimer's & dementia 10 (1), 115-131, 2014 | 335 | 2014 |
| CSF levels of tau, β-amyloid1–42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging M Sjögren, L Minthon, P Davidsson, AK Granerus, A Clarberg, ... Journal of neural transmission 107, 563-579, 2000 | 301 | 2000 |
| Both total and phosphorylated tau are increased in Alzheimer's disease M Sjögren, P Davidsson, M Tullberg, L Minthon, A Wallin, C Wikkelso, ... Journal of Neurology, Neurosurgery & Psychiatry 70 (5), 624-630, 2001 | 298 | 2001 |
| Cytosolic free calcium elevation mediates the phagosome-lysosome fusion during phagocytosis in human neutrophils. SO Jaconi M, Lew P, Carpentier L, Magnusson K-E, Sjogren M J Cell Biol 110 (5), 1555-64, 1990 | 281 | 1990 |
| Treatment of Alzheimer’s disease with clioquinol B Regland, W Lehmann, I Abedini, K Blennow, M Jonsson, I Karlsson, ... Dementia and geriatric cognitive disorders 12 (6), 408-414, 2001 | 275 | 2001 |
| The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition A Nordlund, S Rolstad, P Hellström, M Sjögren, S Hansen, A Wallin Journal of Neurology, Neurosurgery & Psychiatry 76 (11), 1485-1490, 2005 | 272 | 2005 |
| Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. MJ Sjögren, PT Hellström, MA Jonsson, M Runnerstam, HC Silander, ... The Journal of clinical psychiatry 63 (11), 972-980, 2002 | 258 | 2002 |
| Vascular factors and Alzheimer disease I Skoog, RN Kalaria, MMB Breteler Alzheimer Disease & Associated Disorders 13, S106-S114, 1999 | 258 | 1999 |
| Neurofilament protein in cerebrospinal fluid: a marker of white matter changes M Sjögren, M Blomberg, M Jonsson, LO Wahlund, Å Edman, K Lind, ... Journal of neuroscience research 66 (3), 510-516, 2001 | 249 | 2001 |
| Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients P Davidsson, A Westman-Brinkmalm, CL Nilsson, M Lindbjer, L Paulson, ... Neuroreport 13 (5), 611-615, 2002 | 245 | 2002 |
| Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene … M Heilig, O Zachrisson, A Thorsell, A Ehnvall, S Mottagui-Tabar, ... Journal of psychiatric research 38 (2), 113-121, 2004 | 242 | 2004 |
| Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD M Sjogren, L Rosengren, L Minthon, P Davidsson, K Blennow, A Wallin Neurology 54 (10), 1960-1964, 2000 | 210 | 2000 |
| Developing novel blood-based biomarkers for Alzheimer's disease HM Snyder, MC Carrillo, F Grodstein, K Henriksen, A Jeromin, ... Alzheimer's & Dementia 10 (1), 109-114, 2014 | 202 | 2014 |
Ingmar SkoogVerified email at neuro.gu.se
